Sturm, G. J., Herzog, S. A., Aberer, W., Alfaya Arias, T., Antolín‐Amérigo, D., Bonadonna, P., Boni, E., Bożek, A., Chełmińska, M., Ernst, B., Frelih, N., Gawlik, R., Gelincik, A., Hawranek, T., Hoetzenecker, W., Jiménez Blanco, A., Kita, K., Kendirlinan, R., Košnik, M., Laipold, K., Lang, R., Marchi, F., Mauro, M., Nittner‐Marszalska, M., Poziomkowska‐Gęsicka, I., Pravettoni, V., Preziosi, D., Quercia, O., Reider, N., Rosiek‐Biegus, M., Ruiz‐Leon, B., Schrautzer, C., Serrano, P., Sin, A., Sin, B. A., Stoevesandt, J., Trautmann, A., Vachová, M., & Arzt‐Gradwohl, L. (2021). β‐blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy. Allergy, 76(7), 2166–2176. http://access.bl.uk/ark:/81055/vdc_100133931322.0x000051